Fundz

PhaseWell Research acquires Chase Medical Research

PRIVATEMar 18, 2026

Acquiring Company

PhaseWell Research

Acquired Company

Chase Medical Research

NashvilleBiotechnologyHealth CareMedicalBiotechnologyHealth CareMedical

Description

PhaseWell Research has acquired Chase Medical Research to enhance its clinical trial capabilities in Connecticut. This acquisition expands PhaseWell's reach in the Northeast and strengthens its focus on cardiometabolic research. Chase Medical Research adds valuable expertise and community connections to PhaseWell's growing network.

Quick answer

PhaseWell Research is acquiring Chase Medical Research, announced March 18, 2026. PhaseWell Research is based in Nashville, Tennessee, United States.

How much did PhaseWell Research pay for Chase Medical Research?
The deal value was not disclosed.
What does PhaseWell Research do?
PhaseWell Research is a multisite clinical research company focused on increasing participation in clinical trials by offering innovative research opportunities.
Where are PhaseWell Research and Chase Medical Research based?
PhaseWell Research is based in Nashville, Tennessee, United States.
Who are the decision-makers at PhaseWell Research?
Fundz holds 1 contact at PhaseWell Research. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Other recent acquisitions in Medical and Medical

Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.

Who to call at PhaseWell Research, and when

When PhaseWell Research changes hands, the new owners review vendors, systems and leadership. That is when the door opens.

  • An alert the day PhaseWell Research raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at PhaseWell Research, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at PhaseWell Research. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

PhaseWell Research

Location

Nashville, Tennessee, United States

About

PhaseWell Research is a multisite clinical research company focused on increasing participation in clinical trials by offering innovative research opportunities. The company aims to connect communities to clinical trials and advance therapeutic areas. With a national network of high-performing sites, PhaseWell delivers clinical trial services across various therapeutic areas.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment PhaseWell Research makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Leah
Senior decision-maker at this company
••••••••@••••••••

See Leah's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for PhaseWell Research's next move

Learn about Strategic plan

Frequently asked

Who acquired Chase Medical Research?

Chase Medical Research was acquired by PhaseWell Research, based in Nashville. The deal was reported on March 18, 2026. PhaseWell Research is a multisite clinical research company focused on increasing participation in clinical trials by offering innovative research opportunities. PhaseWell Research is privately held and operates in Biotechnology.

When did PhaseWell Research acquire Chase Medical Research?

PhaseWell Research's acquisition of Chase Medical Research was reported on March 18, 2026. PhaseWell Research has acquired Chase Medical Research to enhance its clinical trial capabilities in Connecticut. This acquisition expands PhaseWell's reach in the Northeast and strengthens its focus on cardiometabolic research. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.

What does Chase Medical Research do?

Chase Medical Research specializes in conducting clinical trials across various medical fields including cardiometabolic, central nervous system, and respiratory research. It is privately held, operating in Biotechnology.

This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.